CONVATEC GROUP PLC, a British medical device maker, saw shares fall 8% after reporting slowing revenue growth and warning of rising geopolitical costs. The company posted 1.6% organic revenue growth for the first four months of 2026, down from 6.2% in the prior year. Energy-driven inflation on plastic-heavy production lines threatens margins despite maintained annual guidance.

Geopolitical Conflict Hits Input Costs